Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
12.38
-0.81 (-6.11%)
Mar 31, 2025, 1:41 PM EDT - Market open

Syndax Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
23.68--139.711.52
Upgrade
Revenue Growth (YoY)
---9109.56%-
Upgrade
Cost of Revenue
242.47163.03118.5--
Upgrade
Gross Profit
-218.79-163.03-118.5139.711.52
Upgrade
Selling, General & Admin
120.8866.9233.2625.2422.51
Upgrade
Research & Development
---88.2550.44
Upgrade
Operating Expenses
120.8866.9233.26113.4972.94
Upgrade
Operating Income
-339.67-229.95-151.7626.22-71.42
Upgrade
Interest Expense
-4.93-0.21-3.14-1.9-2.36
Upgrade
Interest & Investment Income
26.0921.165.870.40.84
Upgrade
Other Non Operating Income (Expenses)
-0.25-0.36-0.320.2-0.22
Upgrade
Pretax Income
-318.76-209.36-149.3424.93-73.16
Upgrade
Net Income
-318.76-209.36-149.3424.93-73.16
Upgrade
Preferred Dividends & Other Adjustments
----3.91
Upgrade
Net Income to Common
-318.76-209.36-149.3424.93-77.06
Upgrade
Shares Outstanding (Basic)
8670615241
Upgrade
Shares Outstanding (Diluted)
8670615441
Upgrade
Shares Change (YoY)
21.67%15.82%13.31%29.81%35.48%
Upgrade
EPS (Basic)
-3.72-2.98-2.460.48-1.87
Upgrade
EPS (Diluted)
-3.72-2.98-2.460.46-1.87
Upgrade
Free Cash Flow
-274.9-160.6-133.6829-71.26
Upgrade
Free Cash Flow Per Share
-3.21-2.28-2.200.54-1.73
Upgrade
Gross Margin
---100.00%100.00%
Upgrade
Operating Margin
-1434.43%--18.77%-4708.17%
Upgrade
Profit Margin
-1346.11%--17.84%-5080.03%
Upgrade
Free Cash Flow Margin
-1160.91%--20.76%-4697.43%
Upgrade
EBITDA
-339.66-229.94-151.7226.26-71.33
Upgrade
EBITDA Margin
---18.80%-
Upgrade
D&A For EBITDA
0.010.010.030.040.09
Upgrade
EBIT
-339.67-229.95-151.7626.22-71.42
Upgrade
EBIT Margin
---18.77%-
Upgrade
Revenue as Reported
23.68--139.711.52
Upgrade
Advertising Expenses
7.36.11.5--
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q